Organigram Holdings Inc. announced its second international medical cannabis customer in the UK, Avida Medical, a full-service medical cannabis and specials medicines manufacturing business. Subject to the terms of the Agreement, the Company expects to supply 1,700 kilograms of high-quality, indoor-grown dried cannabis flower to Avida Medical in the UK over a period of three years.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.08 CAD | +2.97% |
|
-1.42% | +20.93% |
06-25 | Organigram to Invest $15 Million in German Cannabis Company Sanity Group | MT |
06-25 | Organigram to Buy Minority Stake in German Cannabis Firm Sanity Group for 14 Million Euros | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.93% | 153M | |
+21.40% | 243M | |
-5.15% | 205M | |
+41.83% | 126M | |
-28.57% | 121M | |
+300.00% | 121M | |
+76.38% | 98.68M | |
0.00% | 87.12M | |
-59.98% | 83.6M |
- Stock Market
- Equities
- OGI Stock
- News Organigram Holdings Inc.
- Organigram Signs Three Year Supply Agreement with Avida Medical in UK